Natural History and Clinical Characteristics of CKD in Type 1 and Type 2 Diabetes Mellitus

被引:39
作者
Marshall, Sally M. [1 ]
机构
[1] Newcastle Univ, Diabet Res Grp, Inst Cellular Med, Fac Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
Diabetic nephropathy; Microalbuminuria/KDIGO CKD albuminuria A2; Proteinuria/KDIGO CKD albuminuria A3; CKD in diabetes; Natural history of diabetic nephropathy; STAGE RENAL-DISEASE; KIDNEY-DISEASE; ALBUMIN EXCRETION; RISK-FACTORS; NEPHROPATHY; COMPLICATIONS; MICROALBUMINURIA; PROGRESSION; INSUFFICIENCY; RETINOPATHY;
D O I
10.1053/j.ackd.2014.03.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The nature of CKD in diabetes is changing. Diabetic glomerulosclerosis remains the cause of CKD in most type 1 diabetic individuals. However, the rate of progression of diabetic nephropathy has slowed because of improving glucose and blood pressure control. Most individuals with type 2 diabetes and 5% to 30% of those with type 1 diabetes with progressive CKD have normal urine albumin excretion or low-level microalbuminuria (albumin-to-creatinine ratio approximately <100 mg/g), which does not progress despite the decline in glomerular filtration. People with progressive CKD but normal albuminuria have predominantly interstitial or vascular changes with much less glomerular changes. It seems likely that these histological abnormalities relate to blood pressure, aging, obesity, and intrarenal vascular disease. Initial studies suggested that 85% to 100% of diabetic individuals with microalbuminuria (Kidney Disease Improving Global Outcomes [KDIGO] CKD albuminuria A2) progressed to proteinuria (KDIGO CKD albuminuria A3). Recent data demonstrate that even after 2 to 3 years of persistent microalbuminuria, most will revert to normal albumin excretion (KDIGO CKD albuminuria A1). Regression is more likely at lower levels of microalbuminuria and with improved glucose, blood pressure, and lipid control. Thus, low levels of microalbuminuria cannot be considered as established diabetic nephropathy. (C) 2014 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 43 条
  • [1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    Adler, AI
    Stevens, RJ
    Manley, SE
    Bilous, RW
    Cull, CA
    Holman, RR
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (01) : 225 - 232
  • [2] The Synergistic Relationship Between Estimated GFR and Microalbuminuria in Predicting Long-term Progression to ESRD or Death in Patients With Diabetes: Results From the Kidney Early Evaluation Program (KEEP)
    Amin, Amit P.
    Whaley-Connell, Adam T.
    Li, Suying
    Chen, Shu-Cheng
    McCullough, Peter A.
    Kosiborod, Mikhail N.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : S12 - S23
  • [3] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
  • [4] Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: A cohort study
    Costacou, Tina
    Ellis, Demetrius
    Fried, Linda
    Orchard, Trevor J.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (05) : 721 - 732
  • [5] High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes
    Dart, Allison B.
    Sellers, Elizabeth A.
    Martens, Patricia J.
    Rigatto, Claudio
    Brownell, Marni D.
    Dean, Heather J.
    [J]. DIABETES CARE, 2012, 35 (06) : 1265 - 1271
  • [6] Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
    de Boer, Ian H.
    Rue, Tessa C.
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Sun, Wanjie
    Zinman, Bernard
    Brunzell, John D.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 412 - 420
  • [7] Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
    Ekinci, Elif I.
    Jerums, George
    Skene, Alison
    Crammer, Paul
    Power, David
    Cheong, Karey Y.
    Panagiotopoulos, Sianna
    McNeil, Karen
    Baker, Scott T.
    Fioretto, Paola
    MacIsaac, Richard J.
    [J]. DIABETES CARE, 2013, 36 (11) : 3620 - 3626
  • [8] Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications
    Eppens, Maike C.
    Craig, Maria E.
    Jones, Timothy W.
    Silink, Martin
    Ong, Stephanie
    Ping, Yeo Jing
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) : 1013 - 1020
  • [9] Feldt-Rasmussen B, 1984, DIABETIC NEPHROPATHY, V3, P101
  • [10] Incidence of end-stage renal disease in patients with type 1 diabetes
    Finne, P
    Reunanen, A
    Stenman, S
    Groop, PH
    Grönhagen-Riska, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14): : 1782 - 1787